The European Commission is set to amend the Biocidal Products Regulation (BPR) to extend the review program for existing biocidal active substances.
Extension of Review Programme under the Biocidal Products Regulation
Extension of Review Programme under the Biocidal Product Regulation
- In terms of data requirements and evaluation criteria, only the scientific criteria to assess endocrine disrupting (ED) properties may be considered as “new” since 2004.
- The extension must not be viewed as an opportunity for applicants to generate new data or make changes in their application.
- The Commission also called for an end to practices such as the "quest for a safe use" during the assessment of applications, where applicants are requested to provide new information during the evaluation when unacceptable risks are identified, or they request Member States to allow them to generate and/or submit new data at their own initiative.
- It should be reconsidered whether there are valid reasons to apply new technical guidance developed by the European Chemicals Agency (ECHA) to already submitted applications.
The Commission incites both applicants and Member States to respect the procedures and rules in the Review Regulation, to ensure a high level of protection of human health, animal health and the environment, as aimed for by the BPR and by the Chemical Strategy for Sustainability.
Read more on this topic in the note of the European Commission: